logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Andrea Botticelli

umberto i/sapienza university hospital
H指数:40
被引数:5,897

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Oral toxicities secondary to TROP2 and HER2-directed antibody drug conjugates: a multicenter retrospective cohort study

靶向TROP2和HER2的抗体偶联药物所致口腔毒性的多中心回顾性队列研究

Oncologist
IF4.2
2026-09-210
OAAI
Paolo J Fantozzi, DDS, PhD; Stephen Sonis, DMD, DMSc; Andrea Botticelli, MD, PhD; Simone Scagnoli, MD, PhD; Monica Verrico, MD, PhD; Giulia Bianchini, MD; Maria Vittoria Bonomo, MD; Chiara Bonadonna, MD; Mathilde Casagrande, DDS; Lucia Borghetti, DDS; Gianluca Tenore, DDS, PhD; Sankalp Das, DDS, MPH; John P Diaz, MD, FACOG, FACS; Umberto Romeo, DDS; Alessandro Villa, DDS, PhD, MPH
Patients’ and oncologists’ perspectives on shared decision-making and treatment communication in HR+/HER2 − advanced breast cancer: a multicountry survey

HR+/HER2−晚期乳腺癌患者和肿瘤科医师对共同决策和治疗沟通的看法：一项多国调查

BMC Cancer
IF3.4
2026-09-100
OA
Alessandra Fabi; Andrea Botticelli; Saverio Cinieri; Gilles Freyer; José Angel García-Sáenz; Angel Guerrero-Zotano; Wolfgang Janni; Tatiana Massarrah Sánchez; Thibaut Reverdy; Michael Untch; Julien Péron
Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities

西米普利单抗在皮肤鳞状细胞癌中的应用：一项关注晚期毒性的长期随访研究

Journal der Deutschen Dermatologischen Gesellschaft
IF3.8
2026-09-060
PRE
Marco Rubatto; Alice Baggi; Roberta Depenni; Michele Guida; Paolo Antonio Ascierto; Paola Queirolo; Ketty Peris; Francesco Spagnolo; Luca Bianchi; Federica De Galitiis; Manuel Zamparini; Ilaria Proietti; Riccardo Marconcini; Andrea Botticelli; Vito Barbieri; Salvatore Alfieri; Maria Concetta Fargnoli; Marcella Occelli; Paolo Fava; Alessio Capacchione; Valentina Comunanza; Paolo Bossi; Pietro Quaglino
Circulating CD137⁺Treg cells and LOX-1⁺PMN-MDSCs as biomarkers of immunotherapy resistance in (R/M) HNSCC patients

外周CD137⁺Treg细胞和LOX-1⁺PMN-MDSCs作为免疫治疗耐药的(R/M)HNSCC患者的生物标志物

Journal of Experimental & Clinical Cancer Research
IF12.8
2025-12-030
OAAI
Angela Asquino; Alessio Cirillo; Lidia Strigari; Angelica Pace; Chiara Napoletano; Lucrezia Tuosto; Flavio Valentino; Andrea Ballario; Daniele Santini; Marianna Nuti; Andrea Botticelli; Aurelia Rughetti; Ilaria Grazia Zizzari
Impact of Body Composition Changes on Treatment-Related Toxicities and Clinical Outcomes in HER2-Positive Metastatic Breast Cancer Patients Receiving Trastuzumab Deruxtecan

HER2阳性转移性乳腺癌患者接受Trastuzumab Deruxtecan治疗时，体成分变化对治疗相关毒性和临床结局的影响

Cancers 2025, Vol. 17, Page 3063
IF0
2025-09-230
OAAI
Alessio Molfino; Giovanni Imbimbo; Simona Pisegna; Simone Scagnoli; Claudia Alabiso; Massimiliano Ardovino; Carmen Gallicchio; Veronica Rizzo; Andrea Botticelli
The evolving landscape of hormone receptor-positive/HER2-negative metastatic breast cancer (EVOLVE): An Italian Delphi consensus report

激素受体阳性/HER2阴性转移性乳腺癌的演变格局（EVOLVE）：一项意大利Delphi共识报告

critical reviews in oncology hematology
IF0
2025-06-060
OA
Federica Miglietta; Maria Grazia Razeti; Aldo Caltavituro; Arianna Dri; Carmine Valenza; Giampaolo Bianchini; Laura Biganzoli; Andrea Botticelli; Michele Caruso; Saverio Cinieri; Carmen Criscitiello; Carmine De Angelis; Michelino De Laurentis; Lucia Del Mastro; Sabino De Placido; Marzia Del Re; Maria Vittoria Dieci; Alessandra Fabi; Daniele Generali; Alessandra Gennari; Grazia Arpino
Clinical relevance and methodological approach for the assessment of drug–drug interactions in cancer patients: a position statement from the Italian Association of Medical Oncology (AIOM) and the Italian Society of Pharmacology (SIF)

癌症患者药物相互作用评估的临床相关性与方法学路径：意大利医学肿瘤学会（AIOM）和意大利药理学学会（SIF）的立场声明

ESMO Open
IF8.3
2025-06-010
OA
M. Del Re; R. Roncato; A. Argentiero; L. Berrino; A. Botticelli; A. Capuano; S. Di Donato; S. Fogli; D. Marino; G. Rodriquenz; D. Speranza; F. Perrone; N. Silvestris; R. Danesi
Process management method in head and neck cancer patient care

头颈癌患者护理中的流程管理方法

DISCOVER ONCOLOGY
IF2.9
2025-05-230
OA
De Felice, Francesca; Valentini, Valentino; Casarano, Francesca; Gaudino, Chiara; Di Gioia, Cira Rosaria Tiziana; Tenore, Gianluca; Della Monaca, Marco; Cassoni, Andrea; Cirillo, Alessio; Corsi, Alessandro; Botticelli, Andrea; Cerbelli, Bruna; Battisti, Andrea; Brauner, Edoardo; Messineo, Daniela; De Virgilio, Armando; Greco, Antonio; Santini, Daniele; Catalano, Carlo; Romeo, Umberto; Della Rocca, Carlo; Polimeni, Antonella; de Vincentiis, Marco
Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors

Denosumab与Zoledronic acid在接收CDK4/6抑制剂的晚期乳腺癌患者中的比较分析

breast
IF0
2025-05-150
OA
Roberta Scafetta; Marco Donato; Carla Gullotta; Alessandra Guarino; Cristina Fiore; Luisana Sisca; Elena Speziale; Raffaella Troiano; Simone Foderaro; Valentina Ricozzi; Michele Iuliani; Sonia Simonetti; Silvia Cavaliere; Alessio Cortellini; Andrea Botticelli; Simone Scagnoli; Simona Pisegna; Carmen Criscitiello; Rebecca Pedersini; Caterina Sposetti; Francesco Pantano
Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR-positive/HER2-negative BC patients: results from the multicenter PALMARES-2 study

真实世界中一线帕博西利、瑞博西利或阿贝西利联合内分泌治疗在晚期HR阳性/HER2阴性乳腺癌患者中的疗效比较：多中心PALMARES-2研究的结果

Annals of Oncology
IF65.4
2025-04-080
PRE
L. Provenzano; M.V. Dieci; G. Curigliano; M. Giuliano; A. Botticelli; M. Lambertini; G. Rizzo; R. Pedersini; M. Sirico; N. La Verde; A. Gennari; A. Zambelli; A. Toss; M. Piras; M. Giordano; B. Tagliaferri; D. Generali; D. Sartori; D. Miliziano; A. Menichetti; R. Coviello
The Rome trial from histology to target: The road to personalize targeted therapy and immunotherapy

罗马试验：从组织学到靶点——个性化靶向治疗和免疫治疗的道路

ANNALS OF ONCOLOGY
IF65.4
2024-09-013
PRE
Botticelli, A.; Scagnoli, S.; Conte, P.; Cremolini, C.; Ascierto, P. A.; Cappuzzo, F.; Aglietta, M.; Mazzuca, F.; Capoluongo, E.; Blandino, G.; Malapelle, U.; Nuti, M.; D'Amati, G.; Cerbelli, B.; Pruneri, G.; Biffoni, M.; Giannini, G.; Cognetti, F.; Curigliano, G.; Marchetti, P.
Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study (vol 10, 58, 2024)

药物-药物相互作用对abemaciclib在AB-意大利研究的真实世界经验中的临床影响 (第10卷，58卷，2024)

NPJ BREAST CANCER
IF7.6
2024-08-020
OAAI
Scagnoli, Simone; Pisegna, Simona; Toss, Angela; Caputo, Roberta; De Laurentiis, Michelino; Palleschi, Michela; de Giorgi, Ugo; Cortesi, Enrico; Fabbri, Agnese; Fabi, Alessandra; Paris, Ida; Orlandi, Armando; Curigliano, Giuseppe; Criscitiello, Carmen; Garrone, Ornella; Tomasello, Gianluca; D'Auria, Giuliana; Vici, Patrizia; Ricevuto, Enrico; Domati, Federica; Piombino, Claudia; Parola, Sara; Scafetta, Roberta; Cirillo, Alessio; Salimbeni, Beatrice Taurelli; Di Lisa, Francesca Sofia; Strigari, Lidia; Preissner, Robert; Simmaco, Maurizio; Santini, Daniele; Marchetti, Paolo; Botticelli, Andrea
Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study

在AB-意大利研究的现实世界经验中，药物-药物相互作用对abemaciclib的临床影响

NPJ BREAST CANCER
IF7.6
2024-07-173
OAAI
Scagnoli, Simone; Pisegna, Simona; Toss, Angela; Caputo, Roberta; De Laurentiis, Michelino; Palleschi, Michela; de Giorgi, Ugo; Cortesi, Enrico; Fabbri, Agnese; Fabi, Alessandra; Paris, Ida; Orlandi, Armando; Curigliano, Giuseppe; Criscitiello, Carmen; Garrone, Ornella; Tomasello, Gianluca; D'Auria, Giuliana; Vici, Patrizia; Ricevuto, Enrico; Domati, Federica; Piombino, Claudia; Parola, Sara; Scafetta, Roberta; Cirillo, Alessio; Salimbeni, Beatrice Taurelli; Di Lisa, Francesca Sofia; Strigari, Lidia; Preissner, Robert; Simmaco, Maurizio; Santini, Daniele; Marchetti, Paolo; Botticelli, Andrea
Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis (vol 24, 430, 2024)

基于Pembrolizumab的一线治疗PD-L1-positive，复发或转移性头颈部鳞状细胞癌: 回顾性分析 (第24卷，430，2024)

BMC CANCER
IF3.4
2024-04-170
OAAI
Cirillo, Alessio; Marinelli, Daniele; Romeo, Umberto; Messineo, Daniela; De Felice, Francesca; De Vincentiis, Marco; Valentini, Valentino; Mezi, Silvia; Valentini, Filippo; Vivona, Luca; Chiavassa, Antonella; Cerbelli, Bruna; Santini, Daniele; Bossi, Paolo; Polimeni, Antonella; Marchetti, Paolo; Botticelli, Andrea
Antinuclear antibodies may predict the development of immune-related adverse events in asymptomatic patients treated with immune checkpoint inhibitors: results from a single-center cohort

抗核抗体可预测免疫检查点抑制剂治疗的无症状患者免疫相关不良事件的发展: 来自单中心队列的结果

CLINICAL AND EXPERIMENTAL MEDICINE
IF3.5
2024-04-100
OAAI
Ceccarelli, Fulvia; Natalucci, Francesco; Picciariello, Licia; Cirillo, Alessio; Olivieri, Giulio; Veroli, Margherita; Pisegna, Simona; Ciancarella, Claudia; Gelibter, Alain; Picone, Vincenzo; Santini, Daniele; Botticelli, Andrea; Conti, Fabrizio

研究方向

暂未获取到该数据
P
Paolo Marchetti
H 指数:67论文数:1,044被引数:1.8万
D
Daniele Santini
H 指数:85论文数:1,348被引数:3.2万
S
Simone Scagnoli
H 指数:19论文数:112被引数:1,143
M
Marianna Nuti
H 指数:39论文数:242被引数:5,596
B
Bruna Cerbelli
H 指数:29论文数:170被引数:2,408
A
Alessio Cirillo
H 指数:9论文数:42被引数:422
P
Patrizia Vici
H 指数:44论文数:394被引数:7,830
A
Alain Gelibter
H 指数:36论文数:363被引数:4,702
L
Laura Pizzuti
H 指数:36论文数:198被引数:4,054
I
Ilaria Grazia Zizzari
H 指数:29论文数:125被引数:2,532